Sionna Therapeutics, Inc. Common Stock (SION)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $150.63M
Last updated: Nov 17, 2026 at 11:05 AM ET
Sionna Therapeutics, Inc. Common Stock (SION) Earnings: Report Dates and Results
Sionna Therapeutics, Inc. Common Stock (SION) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.72, below the -$0.62 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SION has an expected report date of Mar 1, 2027.
Earnings History
Of the 8 quarters below that had an estimate, SION beat 3 and missed 5. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 37.78% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.72 | -$0.62 | -$0.84 - -$0.53 | -16.13% | Miss | N/A | 8 | 2 up, 1 down | Nov 10, 2026 |
| Jun 30, 2026 | -$0.66 | -$0.64 | -$0.69 - -$0.61 | -3.13% | Miss | N/A | 9 | 0 up, 6 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.60 | -$0.50 | -$0.57 - -$0.47 | -20.00% | Miss | N/A | 8 | 1 up, 2 down | May 12, 2026 |
| Dec 31, 2025 | -$0.46 | -$0.71 | -$0.71 - -$0.47 | +35.21% | Beat | N/A | 8 | 0 up, 2 down | Mar 2, 2026 |
| Sep 30, 2025 | -$0.46 | -$0.52 | N/A | +11.54% | Beat | N/A | 2 | 1 up, 1 down | Nov 5, 2025 |
| Jun 30, 2025 | -$0.41 | -$0.45 | -$0.49 - -$0.44 | +8.89% | Beat | N/A | 2 | 1 up, 1 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.62 | -$0.45 | N/A | -37.78% | Miss | N/A | N/A | N/A | May 12, 2025 |
| Dec 31, 2024 | -$3.38 | -$2.68 | N/A | -26.12% | Miss | N/A | N/A | N/A | Mar 20, 2025 |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$1.98 | N/A |
| Jun 30, 2026 | -$1.26 | N/A |
| Dec 31, 2025 | -$1.95 | N/A |
| Jun 30, 2025 | -$1.03 | N/A |
| Dec 31, 2024 | -$3.38 | N/A |
Frequently Asked Questions About SION
When is Sionna Therapeutics, Inc. Common Stock's next earnings date?
Sionna Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 1, 2027.
Did SION beat earnings estimates last quarter?
No. Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.72 for the quarter ended Sep 30, 2026, below the -$0.62 estimate by 16.13%.
What EPS do analysts expect from SION next quarter?
The consensus EPS estimate for Sionna Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.58 from 13 analysts, with estimates from -$0.78 to -$0.33.
How often does SION beat earnings estimates?
Sionna Therapeutics, Inc. Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -5.94%.
SION pages: Overview, Earnings, Forecast, Financials, Competitors